Elena Elez Fernandez

29PUBLICATIONS
262CO-AUTHORS
Predictive and prognostic markersMolecular targetsChemotherapyComputational physiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Apr 21, 2026
Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure.

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory <i>RAS</i>/<i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Apr 16, 2026
BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

|Mar 07, 2026
Simulation-Informed Evaluation of Microvascular Parameter Mapping for Diffusion MR Imaging of Solid Tumours.

Anna Kira Voronova, Olivia Prior, Athanasios Grigoriou

|Jan 12, 2026
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis.

John H Strickler, Andrea Cercek, Salvatore Siena

|Jan 06, 2026
A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design.

Naureen Starling, Elena Elez, John H Strickler

Pageof 5

Frequent Collaborators

12 joint publications

Josep Tabernero

7 joint publications

Javier Ros

6 joint publications

Takayuki Yoshino

5 joint publications

Salvatore Siena